Zacks: Brokerages Anticipate CRH Medical Corporation (NASDAQ:CRHM) Will Announce Earnings of $0.01 Per Share

Brokerages expect that CRH Medical Corporation (NASDAQ:CRHM) will announce $0.01 earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have made estimates for CRH Medical’s earnings, with the lowest EPS estimate coming in at ($0.01) and the highest estimate coming in at $0.02. CRH Medical posted earnings per share of $0.02 in the same quarter last year, which indicates a negative year over year growth rate of 50%. The firm is expected to report its next earnings results on Wednesday, August 7th.

On average, analysts expect that CRH Medical will report full year earnings of $0.05 per share for the current year, with EPS estimates ranging from $0.02 to $0.09. For the next fiscal year, analysts forecast that the firm will report earnings of $0.11 per share, with EPS estimates ranging from $0.03 to $0.17. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that cover CRH Medical.

Shares of NASDAQ CRHM traded down $0.02 during trading hours on Monday, hitting $2.74. 24,246 shares of the stock were exchanged, compared to its average volume of 67,186. The business’s 50 day moving average is $2.85. CRH Medical has a one year low of $2.51 and a one year high of $4.50.

CRH Medical Company Profile

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Recommended Story: Why do analysts give a neutral rating?

Get a free copy of the Zacks research report on CRH Medical (CRHM)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with's FREE daily email newsletter.